MedTrace Logo

BD Veritor™ At-Home and BD Veritor™ Professional

NCT05352581 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1146

Last updated 2023-06-07

No results posted yet for this study

Summary

The BD Veritor™ System is a rapid test that is testing for both COVID-19 and for Influenza This study will try to determine if the BD Veritor™ system can assist in the diagnosis of someone who has upper respiratory infection symptoms. There is both an At-Home self test and test completed by a health care professional that will be completed during this study.

Conditions

  • Upper Respiratory Infection

Interventions

DIAGNOSTIC_TEST

BD Veritor At-Home

BD Veritor At-Home rapid self testing

DIAGNOSTIC_TEST

BD Veritor Professional

BD Veritor Professional rapid test

Sponsors & Collaborators

  • Becton, Dickinson and Company

    lead INDUSTRY

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-21
Primary Completion
2023-03-09
Completion
2023-04-14
FDA Device
Yes

Countries

  • United States
  • Australia
  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05352581 on ClinicalTrials.gov